Silvia Noiman
InvestorVenture Partner at Pontifax Venture Capital
Israel
Writes $10M – $50M checks · typically $25M
Experience
- Bsense Bio Therapeutics LtdExecutive Chairpersoncurrent2025 — present
- Tel Aviv University's Entrepreneurship CenterMentorcurrent2019 — presentTel Aviv District, Israel
- Imel Biotherapeutics IncFounder, CEO & Board Member2019 — 2024Waltham, Massachusetts, United States
- Sentaur BiosciencesBoard Member2019 — 2024
- Kamari PharmaBoard Member2018 — 2023
- Pontifax Venture CapitalVenture partner, entrepreneur and executive2010 — 2023
- VICO Therapeutics B.V.Board Member2019 — 2022Leiden, Provincie Zuid-Holland, Nederland
- Eloxx PharmaceuticalsFounder, Board Member & CEO2013 — 2021
- ABAC TherapeuticsBoard Member2018 — 2019Barcelona, Catalonia, Spain
- ProMining Therapeutics, LTDCo-Founder & Executive Chairwoman2011 — 2015Israel
- Quiet TherapeuticsCo-Founder & Executive Chairwoman2010 — 2015Israel
- cCAM Biotherapeutics (aquired by Merck in July 2015)Founder, Executive Chairwoman, Director2010 — 2015
- FusiMab, LTDFounder & Executive Chairwoman2012 — 2014Israel
- Biovent LTDFounder & Executive Chairwoman2010 — 2013Israel
- Predix PharmaceuticalsFounder and SVP Global Pipline Management2000 — 2006
- EPIX Pharmaceuticals IncSVP, Global Pipeline Management2006
Education
- Tel Aviv UniversityMaster of Business Administration (M.B.A.)
- Tel Aviv UniversityDoctor of Philosophy (Ph.D.)
- Weizmann Institute of SciencePostdoctoral fellowship
Skills & more
Bioinformatics4Biopharmaceuticals3Biotechnology6Business Strategy3Cell BiologyClinical Development3Clinical Trials4Drug Development3Drug Discovery8Entrepreneurship25In Vitro1Life Sciences12
+12 more
LifesciencesMolecular BiologyOncologyPatentsProduct DevelopmentSmall MoleculesStart-upsTechnology TransferRStrategic PlanningStrategyPharmaceutical IndustryFrom Silvia's professional profile.
Colleagues at Pontifax Venture Capital
Asaf Shinar
Director at Pontifax Venture Capital
Iyona Rajkomar
Partner at Pontifax Venture Capital
Lina Kaminski
Principal at Pontifax Venture Capital
Momi Karako
Investment Professional at Pontifax Venture Capital
Ohad Hammer
Investment Professional at Pontifax Venture Capital
Ran Nussbaum
Managing Partner at Pontifax Venture Capital
Tomer Kariv
Chief Executive Officer at Pontifax Venture Capital
Frequently asked questions
- Who is Silvia Noiman?
- Venture Partner at Pontifax Venture Capital
- Where does Silvia Noiman work?
- Silvia Noiman is Venture Partner at Pontifax Venture Capital.
- What check size does Silvia Noiman write?
- Silvia Noiman typically writes checks of $10M – $50M.
- Where did Silvia Noiman go to school?
- Silvia Noiman studied at Tel Aviv University (Master of Business Administration (M.B.A.)); Tel Aviv University (Doctor of Philosophy (Ph.D.)); Weizmann Institute of Science (Postdoctoral fellowship).
Founder mafias
Tel Aviv University mafia60
Also came through, then founded or led a company.
Eyal ShinarFounded Black Ore Technologies +1Irit YanivMBAFounded Digma Medical +1Yuval TalBSc & MScFounded Linguana +1Guy SnirMaster of Business Administration (MBA)Founded Nest Genomics +1Matan TalmiB.Sc.Founded Spinach +1Eran ShiraziB.ScFounded Neo +1
+ 53 more
Weizmann Institute of Science mafia5
Also came through, then founded or led a company.
.jpg)
Pontifax Venture Capital mafia2
Also came through, then founded or led a company.
Same school
Also attended Tel Aviv University378
Matan RoetAssociate at Redpoint VenturesArnon DinurPartner at 83NorthYoram SnirPartner at 83NorthDavid GoldschmidtManaging Director, Head of the Fund at Samsung Catalyst FundAmit ShofarSr. Investment Director at Samsung Catalyst FundRutie AdarInvestments & Innovation Sr. Director, Israel at Samsung Catalyst Fund
+ 372 more
